A pooled RNA interference screen targeting >16,500 genes in a BRAF inhibitor-sensitive melanoma cell line identified NF1 as the highest ranking gene whose knockdown abrogated the growth inhibitory effects of PLX4720, a BRAF inhibitor [107]. This evidence concerns the gene NF1 and melanoma.